PMID- 20169205 OWN - NLM STAT- MEDLINE DCOM- 20100930 LR - 20211020 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 5 IP - 2 DP - 2010 Feb 12 TI - Raptor is phosphorylated by cdc2 during mitosis. PG - e9197 LID - 10.1371/journal.pone.0009197 [doi] LID - e9197 AB - BACKGROUND: The appropriate control of mitotic entry and exit is reliant on a series of interlocking signaling events that coordinately drive the biological processes required for accurate cell division. Overlaid onto these signals that promote orchestrated cell division are checkpoints that ensure appropriate mitotic spindle formation, a lack of DNA damage, kinetochore attachment, and that each daughter cell has the appropriate complement of DNA. We recently discovered that AMP-activated protein kinase (AMPK) modulates the G2/M phase of cell cycle progression in part through its suppression of mammalian target of rapamycin (mTOR) signaling. AMPK directly phosphorylates the critical mTOR binding partner raptor inhibiting mTORC1 (mTOR-raptor rapamycin sensitive mTOR kinase complex 1). As mTOR has been previously tied to mitotic control, we examined further how raptor may contribute to this process. METHODOLOGY/PRINCIPAL FINDINGS: We have discovered that raptor becomes highly phosphorylated in cells in mitosis. Utilizing tandem mass spectrometry, we identified a number of novel phosphorylation sites in raptor, and using phospho-specific antibodies demonstrated that raptor becomes phosphorylated on phospho-serine/threonine-proline sites in mitosis. A combination of site-directed mutagenesis in a tagged raptor cDNA and analysis with a series of new phospho-specific antibodies generated against different sites in raptor revealed that Serine 696 and Threonine 706 represent two key sites in raptor phosphorylated in mitosis. We demonstrate that the mitotic cyclin-dependent kinase cdc2/CDK1 is the kinase responsible for phosphorylating these sites, and its mitotic partner Cyclin B efficiently coimmunoprecipitates with raptor in mitotic cells. CONCLUSIONS/SIGNIFICANCE: This study demonstrates that the key mTOR binding partner raptor is directly phosphorylated during mitosis by cdc2. This reinforces previous studies suggesting that mTOR activity is highly regulated and important for mitotic progression, and points to a direct modulation of the mTORC1 complex during mitosis. FAU - Gwinn, Dana M AU - Gwinn DM AD - Molecular and Cell Biology Laboratory, Dulbecco Center for Cancer Research, La Jolla, California, United States of America. FAU - Asara, John M AU - Asara JM FAU - Shaw, Reuben J AU - Shaw RJ LA - eng GR - P01 CA120964/CA/NCI NIH HHS/United States GR - R01 DK080425/DK/NIDDK NIH HHS/United States GR - HHMI/Howard Hughes Medical Institute/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20100212 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (CRTC2 protein, human) RN - 0 (Cyclin B) RN - 0 (RPTOR protein, human) RN - 0 (Regulatory-Associated Protein of mTOR) RN - 0 (Transcription Factors) RN - 2ZD004190S (Threonine) RN - 452VLY9402 (Serine) RN - EC 2.7.11.22 (CDC2 Protein Kinase) RN - EC 2.7.11.22 (CDK1 protein, human) RN - EC 2.7.11.22 (Cyclin-Dependent Kinases) SB - IM MH - Adaptor Proteins, Signal Transducing/genetics/*metabolism MH - Amino Acid Sequence MH - Binding Sites/genetics MH - CDC2 Protein Kinase/genetics/*metabolism MH - Cell Line MH - Cell Line, Tumor MH - Cyclin B/genetics/metabolism MH - Cyclin-Dependent Kinases MH - HeLa Cells MH - Humans MH - Immunoblotting MH - Immunoprecipitation MH - Mass Spectrometry MH - *Mitosis MH - Molecular Sequence Data MH - Mutagenesis, Site-Directed MH - Phosphorylation MH - Protein Binding MH - Regulatory-Associated Protein of mTOR MH - Sequence Homology, Amino Acid MH - Serine/metabolism MH - Threonine/metabolism MH - Transcription Factors/metabolism MH - Transfection PMC - PMC2820552 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2010/02/20 06:00 MHDA- 2010/10/01 06:00 PMCR- 2010/02/12 CRDT- 2010/02/20 06:00 PHST- 2009/12/17 00:00 [received] PHST- 2010/01/08 00:00 [accepted] PHST- 2010/02/20 06:00 [entrez] PHST- 2010/02/20 06:00 [pubmed] PHST- 2010/10/01 06:00 [medline] PHST- 2010/02/12 00:00 [pmc-release] AID - 09-PONE-RA-14993 [pii] AID - 10.1371/journal.pone.0009197 [doi] PST - epublish SO - PLoS One. 2010 Feb 12;5(2):e9197. doi: 10.1371/journal.pone.0009197.